Identification of a 10-mer peptide from the death domain of MyD88 which attenuates inflammation and insulin resistance and improves glucose metabolism
Biochemical Journal · 2024
DOI: 10.1042/bcj20230369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Journal, 2024. Verfasst von Mehmood Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Structural Biology Division, CSIR-Central Drug Research Institute, Lucknow 226 031 India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: CSIR | Central Drug Research Institute.
Abstract (Originalsprache)
Insulin resistance (IR) is the key pathophysiological cause of type 2 diabetes, and inflammation has been implicated in it. The death domain (DD) of the adaptor protein, MyD88 plays a crucial role in the transduction of TLR4-associated inflammatory signal. Herein, we have identified a 10-residue peptide (M10), from the DD of MyD88 which seems to be involved in Myddosome formation. We hypothesized that M10 could inhibit MyD88-dependent TLR4-signaling and might have effects on inflammation-associated IR. Intriguingly, 10-mer M10 showed oligomeric nature and reversible self-assembly property indicating the peptide's ability to recognize its own amino acid sequence. M10 inhibited LPS-induced nuclear translocation of NF-κB in L6 myotubes and also reduced LPS-induced IL-6 and TNF-α production in peritoneal macrophages of BALB/c mice. Remarkably, M10 inhibited IL-6 and TNF-α secretion in diabetic, db/db mice. Notably, M10 abrogated IR in insulin-resistant L6 myotubes, which was associated with an increase in glucose uptake and a decrease in Ser307-phosphorylation of IRS1, TNF-α-induced JNK activation and nuclear translocation of NF-κB in these cells. Alternate day dosing with M10 (10 and 20 mg/kg) for 30 days in db/db mice significantly lowered blood glucose and improved glucose intolerance after loading, 3.0 g/kg glucose orally. Furthermore, M10 increased insulin and adiponectin secretion in db/db mice. M10-induced glucose uptake in L6 myotubes involved the activation of PI3K/AKT/GLUT4 pathways. A scrambled M10-analog was mostly inactive. Overall, the results show the identification of a 10-mer peptide from the DD of MyD88 with anti-inflammatory and anti-diabetic properties, suggesting that targeting of TLR4-inflammatory pathway, could lead to the discovery of molecules against IR and diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry and Structural Biology Division, CSIR-Central Drug Research Institute, Lucknow 226 031 India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002 India.
ORCID-Profile: Jimut Kanti Ghosh
Förderung
- CSIR | Central Drug Research Institute
Zitieren
APA
Ali, M., Kumari, T., Gupta, A., Akhtar, S., Verma, R. D., & Ghosh, J. K. (2024). Identification of a 10-mer peptide from the death domain of MyD88 which attenuates inflammation and insulin resistance and improves glucose metabolism. Biochemical Journal. https://doi.org/10.1042/bcj20230369
Vancouver
Ali M, Kumari T, Gupta A, Akhtar S, Verma RD, Ghosh JK. Identification of a 10-mer peptide from the death domain of MyD88 which attenuates inflammation and insulin resistance and improves glucose metabolism. Biochemical Journal. 2024. doi:10.1042/bcj20230369
BibTeX
@article{Ali2024,
author = {Ali, Mehmood and Kumari, Tripti and Gupta, Arvind and Akhtar, Sariyah and Verma, Rahul Dev and Ghosh, Jimut Kanti},
title = {Identification of a 10-mer peptide from the death domain of MyD88 which attenuates inflammation and insulin resistance and improves glucose metabolism},
journal = {Biochemical Journal},
year = {2024},
doi = {10.1042/bcj20230369}
}
EUVIMED